Contrast enhanced ultrasonography for the evaluation of liver diseases;Möglichkeiten und wertigkeit der kontrastverstärkten ultraschalluntersuchung in der beurteilung von lebererkrankungen

Viszeralchirurgie

Volumn 37, Issue 3, 2002, Pages 188-196

  Schlottmann, Klaus ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Contrast agents; Harmonic imaging; Lesions; Liver; Ultrasound

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; ECHOGRAPHY; EVALUATION; LIVER DISEASE; LIVER INJURY; SENSITIVITY AND SPECIFICITY;

EID: 0036066790     PISSN: 14353067     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32391     Document Type: Article

References (33)

1. Radiological diagnosis of the liver
2. Ultrasound of focal liver lesions
3. Improved investigation of portal-hepatic veins by echo-enhanced Doppler sonography
4. Doppler ultrasound assessment of TIPS patency and function - The need for echo enhancers
5. Follow-up of TIPSS by color-coded duplex sonography using an ultrasonic signal enhancer. First results
6. Developments in ultrasound contrast media
7. Microbubble contrast agents: A new era in ultrasound
8. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: Early experience
9. Pulse-inversion mode imaging of liver specific microbubbles: Improved detection of subcentimetre metastases
10. Hepatische arterielle Dopplersonographie mit dem ultraschallsignalverstärker levovist®: Eine placebo-kontrollierte, randomisierte studie
11. Prolongation and optimization of Doppler enhancement with a microbubble US contrast agent by using continuous infusion: Preliminary experience
12. Infusion versus bolus of an ultrasound contrast agent: In vivo dose-response measurements of BR1
13. A multicenter, prospective, open label, randomized, controlled phase IIIb study of SH U 508 a (Levovist®) for Doppler signal enhancement in the portal vascular system
14. Use of the ultrasound contrast medium Levovist® in after-care of liver transplant patients. Improved vascular imaging in color Doppler ultrasound
15. Clinical evaluation of contrast-enhanced color Doppler sonography in the differential diagnosis of liver tumors
16. Sonographic evaluation of focal nodular hyperplasias (FNH) of the liver with a transpulmonary galactose-based contrast agent (Levovist®)
17. Contrast-enhanced Doppler ultrasonography in the diagnosis of hepatocellular carcinoma and pre-malignant lesions in patients with cirrhosis
18. Vergleich von konventioneller sonographie, KM-verstärkter pulsinversions-sonographie und 2 phasen-spiral-CT in der detektion von lebermetastasen: Ergebisse einer internationalen multizenterstudie
19. Phaseninversionssonographie in der spätphase von levovist® zur differentialdiagnose zwischen benignen und malignen leberrundherden
20. Focal hepatic masses: Enhancement patterns with SH U 508A and pulse-inversion US
21. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver. Early experience
22. Enhancement of hepatic hemangiomas with levovist® on coded harmonic angiographic ultrasonography
23. Hemangioma-like lesions in chronic liver disease: Diagnostic evaluation in patients
24. Hyperechoic ultrasound (US) pattern of small hepatocellular carcinoma (HCC) in liver cirrhosis: Prevalence and statistical correlations in 419 patients
25. Dynamic sonography of hepatic tumors
26. Hepatocellular carcinoma: Contrast enhancement with Levovist®
27. Ultrasonic Doppler studies of hepatocellular carcinoma and comparison with other hepatic focal lesions
28. Portal vein thrombosis in patients with cirrhosis: Does sonographic detection of intrathrombus flow allow differentiation of benign and malignant thrombus?
29. Percutaneous fine-needle aspiration of portal vein thrombi as a staging technique for hepatocellular carcinoma. Cytologic imdings of 46 patients
30. Vascularity of hepatocellular carcinoma: Assessment with contrast-enhanced second-harmonic versus conventional power Doppler US
31. Hepatic tumors: Contrast agent-enhancement patterns with pulse-inversion harmonic US
32. Therapeutic effect of transcatheter arterial chemoembolization on hepatocellular carcinoma: Evaluation with contrast-enhanced harmonic power Doppler ultrasound
33. Radiofrequency ablation of hepatic metastases: Postprocedural assessment with a US microbubble contrast agent - Early experience